Global Home Infusion Therapy Market Size Expected To Reach USD 35.78 Billion With CAGR 6.53% By 2030
The Global Home Infusion Therapy Market size is expected to grow from USD 21.57 billion in 2022 to USD 35.78 billion by 2030, at a CAGR of 6.53% during the forecast period (2023-2030).
The intravenous or subcutaneous injection of medications or biologicals to a patient at home is termed home infusion therapy. The medicine (antivirals, immune globulin), equipment (pump), and supplies (tubing and catheters) are required for home infusion. Oral medication can be replaced by home infusion therapy. Nurses typically educate patients or caregivers on how to self-administer the medicine, educate them on side effects and therapeutic goals, and visit the infusion site regularly to monitor the infusion site and change the dressing. Patients, physicians, hospital discharge planners, health plans, home infusion pharmacies, and, if required, home health organizations must all work together to make the home infusion process a success. Traditionally, this procedure has been utilized in hospitals, and individuals can choose from a variety of home infusion treatments provided by professionals.
Top Key Players Covered in The Home Infusion Therapy Market
CVS/Coram, Option Care Health, BriovaRx/Diplomat (UnitedHealth Optum), PharMerica, Fresenius Kabi, ICU Medical Inc., B. Braun Melsungen AG, Baxter, BD, Caesarea Medical Electronics, Smiths Medical, Terumo Corporation, JMS Co. Ltd and others major players.
Request for a Sample Report @
https://introspectivemarke...
The Global Home Infusion Therapy Market size is expected to grow from USD 21.57 billion in 2022 to USD 35.78 billion by 2030, at a CAGR of 6.53% during the forecast period (2023-2030).
The intravenous or subcutaneous injection of medications or biologicals to a patient at home is termed home infusion therapy. The medicine (antivirals, immune globulin), equipment (pump), and supplies (tubing and catheters) are required for home infusion. Oral medication can be replaced by home infusion therapy. Nurses typically educate patients or caregivers on how to self-administer the medicine, educate them on side effects and therapeutic goals, and visit the infusion site regularly to monitor the infusion site and change the dressing. Patients, physicians, hospital discharge planners, health plans, home infusion pharmacies, and, if required, home health organizations must all work together to make the home infusion process a success. Traditionally, this procedure has been utilized in hospitals, and individuals can choose from a variety of home infusion treatments provided by professionals.
Top Key Players Covered in The Home Infusion Therapy Market
CVS/Coram, Option Care Health, BriovaRx/Diplomat (UnitedHealth Optum), PharMerica, Fresenius Kabi, ICU Medical Inc., B. Braun Melsungen AG, Baxter, BD, Caesarea Medical Electronics, Smiths Medical, Terumo Corporation, JMS Co. Ltd and others major players.
Request for a Sample Report @
https://introspectivemarke...
07:27 AM - Dec 27, 2023 (UTC)
